Clinical Trials
30 trialsFOLL-OV
Uppsala University Hospital
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
NEO
University Health Network, Toronto
Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor
University Health Network, Toronto
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Guangxi Medical University
MIRRORS-RCTP
Royal Surrey County Hospital NHS Foundation Trust
BEACON
Peter MacCallum Cancer Centre, Australia
SELENIUM
Seoul National University Hospital
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer
Ruijin Hospital
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
GOGER-01
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma
Yonsei University
HIPEC After Initial CRS in Patients Who Have Received NACT
Northwell Health
BriTROC-2
Cancer Research UK, Glasgow
MITO 27
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MITO25
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
University Hospital Southampton NHS Foundation Trust
AVANIRA3
Jiangsu Cancer Institute & Hospital
MIRRORS
Royal Surrey County Hospital NHS Foundation Trust
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin
Massachusetts General Hospital
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer
M.D. Anderson Cancer Center
ROCOCO
Seoul National University Hospital
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
HIPEC/IPHC
Bay Area Gynecology Oncology
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
British Columbia Cancer Agency
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
National University Hospital, Singapore
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
CARCINOHIPEC
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Korean Gynecologic Oncology Group